Viromed Medical AG (ETR:VME)
Germany · Delayed Price · Currency is EUR 5.40
-0.10 (-1.82%)
Last updated: Sep 15, 2026, 5:30 PM CET
Viromed Medical AG Revenue
In the year 2025, Viromed Medical AG had annual revenue of 5.09M EUR with 352.27% growth. Viromed Medical AG had revenue of 2.67M in the half year ending December 31, 2025.
Revenue
5.09M
Revenue Growth
+352.27%
P/S Ratio
22.56
Revenue / Employee
299.24K
Employees
17
Market Cap
114.75M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 5.09M | 3.96M | 352.27% |
| Dec 31, 2024 | 1.12M | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Bayer Aktiengesellschaft | 45.38B |
| Fresenius SE & Co. KGaA | 23.28B |
| Siemens Healthineers AG | 23.17B |
| Merck KGaA | 21.14B |
| Medios AG | 2.16B |
| MEDICLIN Aktiengesellschaft | 819.84M |
| FamiCord AG | 87.78M |
| LIMES Schlosskliniken AG | 56.72M |